SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,784 | +13.6% | 22,544 | +7.3% | 0.02% | +15.0% |
| Q2 2023 | $2,405,607 | -23.8% | 21,006 | -8.2% | 0.02% | -28.6% |
| Q1 2023 | $3,155,067 | +9.5% | 22,891 | +2.9% | 0.03% | 0.0% |
| Q4 2022 | $2,881,730 | +15.4% | 22,239 | -1.5% | 0.03% | +7.7% |
| Q3 2022 | $2,497,000 | +48.6% | 22,589 | +0.8% | 0.03% | +62.5% |
| Q2 2022 | $1,680,000 | -3.8% | 22,418 | +0.3% | 0.02% | +14.3% |
| Q1 2022 | $1,747,000 | -5.0% | 22,361 | +9.5% | 0.01% | 0.0% |
| Q4 2021 | $1,838,000 | -3.7% | 20,415 | -1.1% | 0.01% | -12.5% |
| Q3 2021 | $1,909,000 | +19.8% | 20,643 | +0.7% | 0.02% | +23.1% |
| Q2 2021 | $1,594,000 | -1.1% | 20,509 | -5.1% | 0.01% | -7.1% |
| Q1 2021 | $1,611,000 | -55.8% | 21,615 | +1.1% | 0.01% | -57.6% |
| Q4 2020 | $3,646,000 | +15.2% | 21,386 | -5.1% | 0.03% | +6.5% |
| Q3 2020 | $3,166,000 | +14.7% | 22,543 | +31.0% | 0.03% | -20.5% |
| Q2 2020 | $2,760,000 | +64.5% | 17,211 | +0.3% | 0.04% | +34.5% |
| Q1 2020 | $1,678,000 | – | 17,154 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |